MidAmerica Healthcare Venture Forum

The MidAmerica Healthcare Venture Forum, partnered with MedCityNews.com, unites active investors with corporate business development executives to syndicate investment opportunities with promising Midwest-based healthcare start-ups.

MedCity Media and MHIN (Mid-America Healthcare Investors Network) will unite active investors with corporate business development executives to syndicate investment opportunities with promising Mid-America based start-ups from the medical devices, diagnostics, healthcare IT, agri-health, regenerative medicine, biopharmaceuticals and industrial biotech sectors.

April 22-23 in Chicago.

Learn more here.

DreamIt Ventures

Have a creative idea? Want to start a company with it?

Interested in getting free mentoring, learning more about DreamIt's accelerator programs, and speaking with the DreamIt team about your idea? Now's the time!

• DreamIt has launched 127 companies.
• DreamIt companies have raised $103M in follow on funding.
• DreamIt Companies have an enterprise value greater than $385M.

DreamIt Partners Kerry Rupp, Steve Welch, and Elliot Menschik are heading out around the United States to meet entrepreneurs and startups interested in mentoring and learning about the DreamIt programs.

Learn more about those programs here.

12th Annual BIO Investor Forum

Don't miss the 12th Annual BIO Investor Forum

BIO Investor Forum
October 8-9, 2013
San Francisco

The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and One-on-One partnering meetings.

Follow BIO Investor Forum on Twitter, and join the conversation:#BIF13

Learn more here: http://www.bio.org/events/conferences/12th-annual-bio-investor-forum

Telemedicine Venture Fair at ATA 2013

Interested in working with some telemedicine startups?

Don't miss the Telemedicine Venture Fair at ATA 2013. This is a pre-conference event that requires separate registration. The Venture Fair is on Sunday, May 5.

Register now for ATA 2013 - American Telemedicine Association
May 5 - 7, 2013
Austin, TX


Used code "LinkedInATA" for $50 off your full meeting (non-member) registration. After April 1, the registration price goes up.

Join 6,000 healthcare and technology professionals at the world's largest telemedicine meeting. Featuring over 450 presentations on telehealth and mHealth and industry expo.

Learn more at http://www.americantelemed.org

15th Annual Angel Venture Fair

The 15th Annual Angel Venture Fair, which is the largest gathering of angel investors and entrepreneurs in the Mid-Atlantic Region, will take place Tuesday, April 30 from 7:30 a.m. to 4 p.m. at Houston Hall at the University of Pennsylvania.

Investors will meet 35 entrepreneurs vetted by over 80 judges across all industries. This year we will be hosting Jeff Bussgang, general partner at Flybridge Capital Partners and author of "Mastering the VC Game".

The following are links to for entrepreneurs and investors:
Entrepreneur Applications
Purchase Tickets

DreamIt Health - Dreamit Ventures

DreamIt Health is a four-month startup accelerator located in the heart of Philadelphia; a microcosm of the national health care industry. The intense 16-week cycle is designed to give nascent health IT ventures unfair advantages in the market. DreamIt Health provides access to critical health care-specific resources and beta customers; up to $50,000 in seed funding; collaborative office space; uniquely assigned, one-on-one, in-depth mentoring; world-class coaching and networking with industry experts; and the opportunity to present to a room full of investors on Demo Day.

Companies participating in the program benefit from the unique collaboration of the region's dominant health care payor (Independence Blue Cross) and provider (Penn Medicine) joining forces to speed innovations to market in Philadelphia and beyond.

Learn more here.

National Association of Seed & Venture Funds (NASVF)

The National Association of Seed & Venture Funds (NASVF) is an international membership organization that advocates for the growth of seed and early-stage innovation capital. NASVF connects the people in the world of venture capital and regional economic development. We collaborate with public and private fund managers and tech transfer professionals, the folks who are committed to building their local economies by investing in entrepreneurs.

Learn more here: http://www.nasvf.org

Job Post: Private Equity Senior Associate

Private Equity Senior Associate
OrbiMed Adivsors, LLC
New York, NY 10022

The Private Equity Senior Associate will support senior members of the private equity/venture capital team at OrbiMed Advisors, LLC (www.orbimed.com) a health care-dedicated organization with a successful 20 year track record and more than $5B in assets under management.

The Senior Associate will play an integral supporting role in the generation of new investment ideas, in conducting due diligence for new investments, and in the management of current portfolio positions. The successful candidate will have a strong scientific and/or clinical background and be able to understand, interpret, and integrate information from diverse therapeutic areas in order to reach investment conclusions. It will also be critically important for candidates to understand business principles and market dynamics in the drug and medical device sectors.

Specific activities will include financial modeling using Excel, working with consultants to perform scientific and financial due diligence, preparing PowerPoint presentations for both internal and external audiences, working with attorneys to draft term sheets and investment documents, analyzing data from various information vendors, and maintaining proprietary firm databases. The complexity of work projects would be expected to increase as the Senior Associate develops. The position is designed to last for 2-3 years, but potentially could be extended for select candidates. The position provides an exceptional opportunity for individuals interested in gaining experience in healthcare private equity & venture capital investing.

Contact: vcresumes@orbimed.com

MIT Venture Mentoring Service (VMS)

MIT is recognized worldwide as a leader in innovation and enterprise. The Institute counts many industrial leaders among its graduates, including Alfred P. Sloan, Arthur D. Little, Alfred du Pont, William R. Hewlett, Amar G. Bose and Robert M. Metcalfe. In recent decades MIT alumni and faculty have founded thousands of successful companies and created millions of jobs.

Today's emerging MIT entrepreneurs, however, face an unusually fast-moving and competitive business environment. The speed of technological changes, accelerated product cycles, global competition and sophisticated financing strategies often demand resources and experience beyond the reach of the typical start-up. Through its unique mentoring process, VMS offers the help that's needed to confront these complexities.

Dreamit Ventures

The DreamIt founders designed DreamIt to be the startup accelerator program they wish existed when they started and sold their first companies. New startups today need only a little funding, but they need more help and support than ever before. They need a community of fellow entrepreneurs to share ideas and inspiration, technologists to join their team, Mentors and coaches who have struggled on their way to a big success, legal and accounting services that don't cost precious cash, and opportunities to meet and pitch angel investors and venture capitalists.

So how does DreamIt work? It all starts with bright, energetic people with great ideas. People like you. Then DreamIt adds all the help and support you need to build the next great company.

Job Post: Healthcare Analyst - Biotherapeutics

Healthcare Analyst - Biotherapeutics
ACM - New York, NY 10017

New York based global long-short healthcare fund seeks candidate with an advanced life sciences or medical degree. The candidate will work directly with the portfolio manager as an integral member of the investment team. Our firm covers biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services and facilities. One of our firm's Managing Directors was formerly a senior official with the U.S. FDA and CMS, among other great colleagues.

Responsibilities include:

• Financial modeling
• Conducting market research in repsect of therapeutic categories of interest
• Conducting clinical and regulatory due diligence
• Assuming a key role in portfolio monitoring

Qualified candidates will possess:

• Excel-based modeling capabilities
• Knowledge of financial statements
• Strong communication and writing skills

10th Annual MedTech Investing Conference (Medical Devices)

Uniting the Venture Capital Community with Start-up CEOs and Corporate Executives to Drive Innovation and Investment Opportunities in the Multi-Billion Dollar Medical Device Market.

With increasing regulatory hurdles, medical device start-ups need to adopt new strategies to accelerate the time to market. This year's conference will focus on 'Navigating the Changing Landscape' with first hand perspectives and case-studies. International Business Forum and LifeScience Alley co-present this conference each year as a central gathering place for the leading MedTech VCs, CEOs, Corporates, and Investment Bankers to facilitate dealflow, share information, address concerns and explore new opportunities together.

May 18-19, 2011
Graves 601 Hotel Minneapolis
601 1st Avenue North
Minneapolis, MN, 55403

More information here: http://medtechconference.com/home.html

Physicians earning income outside of medicine (Business Pitch)

On the American Medical News website, you'll find a section there titled, "Business Pitch." There, you can read about physicians who are turning their interests outside of medicine into business ventures. Here are some examples of recent stories:

• Physician delivers maternity lab coats - Feb. 7
• From family medicine to family reading - Jan. 24
• Doctor/runner uses bare foot as shoe model - Nov. 8
• Doctor sells coffee to help Rwanda's poor - Sept. 20
• Making movies and TV shows a family affair - Sept. 6
• Doctor creates software to help kids "think like a king" - Aug. 16
• Orthopedic surgeon keeps homes environmentally sound - Aug. 2
• Ohio pulmonologist establishes artists' retreat - July 19
• Doctor's honey makes money for Tenn. hospital - May 31
• Tough toenails? Doctor's "piggy paste" goes to market - April 19
• N.Y. pediatrician takes child's play to the mat - March 1

Read these stories here.

22nd Annual Venture Capital Investing Conference

Over Two Decades of Convening the Venture Capital Investing Community. The IBF Venture Capital Investing Conference is the Premier Industry Gathering For VCs and LPs:

IBF organized the first Venture Capital Investing Conference back in 1989 and has continued to unite venture capitalists and limited partners each June. Set in San Francisco, this event is consistently regarded as the most important gathering of its kind, uniting hundreds of venture firms – those who pave the way for the expanded path of the industry. IBF is privileged to celebrate the 21st annual event, as now more than ever, VC investors and limited partners need to speak to each other and understand the changed landscape for investing.

Audience Profile:

Venture capitalists, institutional investors, corporate investors, limited partners, pension funds, endowments and foundations and other private equity investors.

June 7-9, 2011
Sofitel San Francisco Bay

IBF - International Business Forum presents leading-edge conferences on technology innovation, venture capital, private equity investing, innovation partnering, corporate strategic investing, technology transfer and technology commercialization and investing opportunities. Established in 1989, International Business Forum has provided attendees with market intelligence in such sectors as information technology, life sciences, healthcare, and the commercialization and investing opportunities in emerging innovative technology sectors.

Intellectual Ventures

Wouldn't it be fun to invent something with a group of intelligent people? Maybe you have a creative medical idea. Perhaps you'd like to build new medical device. Intellectual Ventures provides that opportunity. Here's some information about this interesting company:

Intellectual Ventures is the global leader in the business of invention. We collaborate with leading inventors, partner with pioneering companies, and invest both expertise and capital in the development and monetization of inventions and patent portfolios. Our mission is to energize and streamline an invention economy that will drive innovation around the world.

Intellectual Ventures is building an active market for invention that brings together expertise and capital, and links buyers with sellers. We see great opportunities for inventors, companies, investors, partners, and world economies to benefit from a global market for invention.

2010 Life Sciences & Healthcare Venture Summit

The Life Sciences & Healthcare Venture Summit presented by youngStartup Ventures, is the premier bioscience industry gathering, connecting the CEOs of early stage and emerging growth biotech, pharmaceutical, healthcare, medical device, healthcare IT and diagnostic companies with venture capitalists, angel investors, corporate VCs, investment bankers and professional service firms.

Whether you're seeking funding, partnerships or new investment opportunities, The Life Sciences & Healthcare Venture Summit, now in its 7th year, is one event you won't want to miss.

This premier forum for the emerging growth bioscience industry will feature:

• 35+ Venture Capital Speakers
• 5 Venture Capital Panels
• 50 of the Hottest Emerging Companies Seeking Funding
• Emerging Company Presentations
• High Level Networking Opportunities

Audience Profile: Venture Capitalists, angel investors, corporate VCs, CEOs, CFOs and other senior management of early stage and emerging growth ventures, technology transfer professionals and premium services firms.

Oct 21, 2010 in New York City. Learn more here.

Struggling to make decisions about business school

Many of you know that I've been thinking about business school for many years. The biggest struggle I'm having right now is that I'm getting more involved with side ventures and they're eating up my time. I'd like to spend more time with my family, but I'm simply doing too many things (blogging, consulting, etc.). So, how does business school fit into this mix?

• Am I willing to give up 2 weekends each month to pursue an executive MBA?
• A part-time MBA would give me much more flexibility, but I may not gain the same level of networking opportunities. 
• Should I spend more time with these side ventures? That would delay my plans for business school.

Earlier this year, I was certain that I'd be enrolled in an MBA program in 2010. Now, I'm less certain because I remain concerned that I don't have enough time for work, family, blogging, consulting, side ventures, and sleep! At least I know that I won't need to worry about the GMAT since many MBA programs will waive the GMAT if you have a terminal degree.

I'm hoping that after I attend the MD/MBA conference in Boston this weekend, I'll get some more clarity about this issue.

From R&D to Venture Capital

John LaMattina, PhD, was the former Pfizer president of global R&D (Research and Development). He has now joined the Boston-based venture firm PureTech Ventures as senior partner. LaMattina spent 30 years at Pfizer and I wonder how many years he will spend at PureTech Ventures. Several members of the PureTech Ventures team are MIT graduates (if you're in Boston, that's going to be expected). Some of the associates and partners have PhDs or MDs. Considering a non-clinical career with a venture capital (VC) firm?

Here's a brief snippet about PureTech Ventures:

We specialize in company creation and early-stage investment in novel therapeutics, medical devices, diagnostics, and research technologies. We focus on major unmet medical needs that have yet to be addressed by emerging science. Enlisting the world’s leading academic and industry experts, we identify novel technologies (often prior to publication) and create companies that drive those discoveries to commercially and clinically driven milestones. Once those milestones are achieved, we build out the leadership team, create syndicates for later stage financing rounds, and position the technology to make the broadest impact through public financing or acquisition.

Going back to Pfizer now: Pfizer is splitting its R&D operations into a biotherapeutics division which will be headed by Mikael Dolsten and a pharmatherapeutics division which will be headed by Martin Mackay.